🏛️ Verified NIH Record • Updated 2025-10-06
Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study) (NCT04365374)
A Phase 3 Randomized Controlled Trial of Post-Surgical Stereotactic Radiotherapy (SRT) Versus Surgically Targeted Radiation Therapy (STaRT) With Gamma Tile for Treatment of Newly Diagnosed Metastatic Brain Tumors.
🔵 Active, Not Recruiting Phase3 ⚙️ Medical Device Protocol Sponsor: GT Medical Technologies, Inc.
🩺 Plain-English Summary (8th-Grade Level)
This trial will be a randomized controlled study comparing the efficacy and safety of intraoperative radiation therapy using GammaTilesTM (GT) versus SRT 3-4 weeks following metastatic tumor resection which is the current standard of care.
Who can join: Review the eligibility criteria below.
Location: HonorHeath Scottsdale Osborn Medical Center — Phoenix, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (37 Sites)
Showing the first 25 of 37 sites.
- HonorHeath Scottsdale Osborn Medical Center — Phoenix, Arizona
- University of Arkansas Medical Center — Little Rock, Arkansas
- Ascension St. Vincent's- Riverside — Jacksonville, Florida
- Baptist MD Anderson Cancer Center- Jacksonville — Jacksonville, Florida
- HCA Florida First Coast Neurology- Orange Park — Orange Park, Florida
- Advent health Orlando — Orlando, Florida
- Orlando Health — Orlando, Florida
- Florida Health Sciences Center, Inc. d/b/a Tampa General Hospital — Tampa, Florida
- Piedmont Hospital — Atlanta, Georgia
- Winship Cancer Institute of Emory University — Atlanta, Georgia
- RUSH University — Chicago, Illinois
- Indiana University, IU Health Methodist Hospital — Indianapolis, Indiana
- The University Of Kansas Cancer Center — Kansas City, Kansas
- University of Louisville — Louisville, Kentucky
- Henry Ford Health — Detroit, Michigan
- Abbott Northwestern Hospital — Minneapolis, Minnesota
- University Of Minnesota — Minneapolis, Minnesota
- Ellis Fischel Cancer Center at University of Missouri — Columbia, Missouri
- SSM Health Saint Louis University Hospital — St Louis, Missouri
- Dartmouth-Hitchcock — Lebanon, New Hampshire
- HMH Jersey Shore University Medical Center — Neptune City, New Jersey
- Albany Medical Center — Albany, New York
- Memorial Sloan Kettering — New York, New York
- Westchester Medical Center — Westchester, New York
- University of North Carolina Health — Chapel Hill, North Carolina
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Brain Metastases
- Preop fSRS for Resectable Brain Metastases — Tampa, Florida
- Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases — Washington D.C., District of Columbia
- Study Assessing QBS72S For Treating Brain Metastases — Palo Alto, California
- A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on Immunotherapy — Houston, Texas
- Neurocognitive Decline in Patients With Brain Metastases — Dallas, Texas
- MRI Following Stereotactic Radiosurgery (SRS) for Brain Metastases — Durham, North Carolina
Explore by condition: All Brain Metastases clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.